Robin Kate Kelley (R Kate Kelley, R Katie Kelley, Robin K Kelley)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 30

Top Topics

Metastatic Colorectal Cancer

Epidermal Growth Factor Receptor

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

JCO precision oncology

The New England journal of medicine

JCO oncology practice

This page only lists publications with an associated author ORCID identifier.

Publications

Bruno Sangro, Peter R Galle, Robin Kate Kelley, Chaiyut Charoentum, Enrico N De Toni, Yurii Ostapenko, Jeong Heo, Ann-Lii Cheng, Andrea Wilson Woods, Charu Gupta, Jayne Abraham, Carrie L McCoy, Nikunj Patel, Alejandra Negro, Arndt Vogel, Ghassan K Abou-Alfa
Patient-Reported Outcomes From the Phase III HIMALAYA Study of Tremelimumab Plus Durvalumab in Unresectable Hepatocellular Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (23) (2024)
Nicholas G Zaorsky, Erin B Kennedy, Ghassan K Abou-Alfa, Richard S Finn, Terence P F Gade, Robin Kate Kelley, Tamar Hamosh Taddei, John D Gordan
Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline Update Clinical Insights. JCO oncology practice (2024)
Erica S Tsang, Mallika S Dhawan, Romain Pacaud, Scott Thomas, Jennifer Grabowsky, Lauren Wilch, Silpa Karipineni, Robin Kate Kelley, Andrew H Ko, Eric Collisson, Jocelyn S Chapman, Stefanie Ueda, Emily K Bergsland, Pamela Munster
Synthetic Lethality Beyond BRCA: A Phase I Study of Rucaparib and Irinotecan in Metastatic Solid Tumors With Homologous Recombination-Deficiency Mutations Beyond BRCA1/2. JCO precision oncology 8 (2024)
John D Gordan, Erin B Kennedy, Ghassan K Abou-Alfa, Eliza Wright Beal, Richard S Finn, Terence P F Gade, Laura Goff, Shilpi Gupta, Jennifer Guy, Hang T Hoang, Renuka Iyer, Ishmael Jaiyesimi, Minaxi P Jhawer, Asha Karippot, Ahmed Omar Kaseb, Robin Kate Kelley, Jeremy Kortmansky, Andrea Leaf, William M Remak, Davendra P S Sohal, Tamar Hamosh Taddei, Andrea Wilson Woods, Mark Yarchoan, Michal G Rose
Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
John D Gordan, Erin B Kennedy, Ghassan K Abou-Alfa, Eliza Wright Beal, Richard S Finn, Terence P F Gade, Laura Goff, Shilpi Gupta, Jennifer Guy, Hang T Hoang, Renuka Iyer, Ishmael Jaiyesimi, Minaxi P Jhawer, Asha Karippot, Ahmed Omar Kaseb, Robin Kate Kelley, Jeremy Kortmansky, Andrea Leaf, William M Remak, Davendra P S Sohal, Tamar Hamosh Taddei, Andrea Wilson Woods, Mark Yarchoan, Nicholas G Zaorsky
Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (15) (2024)
Bruno Sangro, Peter R Galle, Robin Kate Kelley, Chaiyut Charoentum, Enrico N De Toni, Yurii Ostapenko, Jeong Heo, Ann-Lii Cheng, Andrea Wilson Woods, Charu Gupta, Jayne Abraham, Carrie L McCoy, Nikunj Patel, Alejandra Negro, Arndt Vogel, Ghassan K Abou-Alfa
Patient-Reported Outcomes From the Phase III HIMALAYA Study of Tremelimumab Plus Durvalumab in Unresectable Hepatocellular Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (23) (2024)
Erica S Tsang, Mallika S Dhawan, Romain Pacaud, Scott Thomas, Jennifer Grabowsky, Lauren Wilch, Silpa Karipineni, Robin Kate Kelley, Andrew H Ko, Eric Collisson, Jocelyn S Chapman, Stefanie Ueda, Emily K Bergsland, Pamela Munster
Synthetic Lethality Beyond BRCA: A Phase I Study of Rucaparib and Irinotecan in Metastatic Solid Tumors With Homologous Recombination-Deficiency Mutations Beyond BRCA1/2. JCO precision oncology 8 (2024)
Bruno Sangro, Peter R Galle, Robin Kate Kelley, Chaiyut Charoentum, Enrico N De Toni, Yurii Ostapenko, Jeong Heo, Ann-Lii Cheng, Andrea Wilson Woods, Charu Gupta, Jayne Abraham, Carrie L McCoy, Nikunj Patel, Alejandra Negro, Arndt Vogel, Ghassan K Abou-Alfa
Patient-Reported Outcomes From the Phase III HIMALAYA Study of Tremelimumab Plus Durvalumab in Unresectable Hepatocellular Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Emily L Zeme, Katherine Van Loon, Robin Kate Kelley, John D Gordan
Emerging Therapies for the Management of Human Epidermal Growth Factor Receptor 2-/ ERBB2 -Altered Advanced Biliary Tract Cancers. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Nicholas G Zaorsky, Erin B Kennedy, Ghassan K Abou-Alfa, Richard S Finn, Terence P F Gade, Robin Kate Kelley, Tamar Hamosh Taddei, John D Gordan
Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline Update Clinical Insights. JCO oncology practice 20 (8) (2024)
Bruno Sangro, Peter R Galle, Robin Kate Kelley, Chaiyut Charoentum, Enrico N De Toni, Yurii Ostapenko, Jeong Heo, Ann-Lii Cheng, Andrea Wilson Woods, Charu Gupta, Jayne Abraham, Carrie L McCoy, Nikunj Patel, Alejandra Negro, Arndt Vogel, Ghassan K Abou-Alfa
Patient-Reported Outcomes From the Phase III HIMALAYA Study of Tremelimumab Plus Durvalumab in Unresectable Hepatocellular Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (23) (2024)
Lipika Goyal, Funda Meric-Bernstam, Antoine Hollebecque, Juan W Valle, Chigusa Morizane, Thomas B Karasic, Thomas A Abrams, Junji Furuse, Robin Kate Kelley, Philippe A Cassier, Heinz-Josef Klümpen, Heung-Moon Chang, Li-Tzong Chen, Josep Tabernero, Do-Youn Oh, Amit Mahipal, Markus Moehler, Edith P Mitchell, Yoshito Komatsu, Kunihiro Masuda, Daniel Ahn, Robert S Epstein, Abdel-Baset Halim, Yao Fu, Tehseen Salimi, Volker Wacheck, Yaohua He, Mei Liu, Karim A Benhadji, John A Bridgewater, null null
Futibatinib for FGFR2 -Rearranged Intrahepatic Cholangiocarcinoma. The New England journal of medicine 388 (3) (2023)
Leontios Pappas, Islam Baiev, Stephanie Reyes, Andrea Grace Bocobo, Apurva Jain, Kristen Spencer, Tri Minh Le, Osama E Rahma, Jordan Maurer, Jen Stanton, Karen Zhang, Anaemy Danner De Armas, Thomas T Deleon, Marc T Roth, Mary Linton B Peters, Andrew X Zhu, Kylie Boyhen, Christine VanCott, Tushar Patel, Lewis Rowland Roberts, Stacie Lindsey, Nora Horick, Jochen K Lennerz, A John Iafrate, Laura Williams Goff, Kabir Mody, Mitesh J Borad, Rachna T Shroff, Milind M Javle, Robin Kate Kelley, Lipika Goyal
The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma. JCO precision oncology 7 (2023)
Lipika Goyal, Funda Meric-Bernstam, Antoine Hollebecque, Juan W Valle, Chigusa Morizane, Thomas B Karasic, Thomas A Abrams, Junji Furuse, Robin Kate Kelley, Philippe A Cassier, Heinz-Josef Klümpen, Heung-Moon Chang, Li-Tzong Chen, Josep Tabernero, Do-Youn Oh, Amit Mahipal, Markus Moehler, Edith P Mitchell, Yoshito Komatsu, Kunihiro Masuda, Daniel Ahn, Robert S Epstein, Abdel-Baset Halim, Yao Fu, Tehseen Salimi, Volker Wacheck, Yaohua He, Mei Liu, Karim A Benhadji, John A Bridgewater, null null
Futibatinib for FGFR2 -Rearranged Intrahepatic Cholangiocarcinoma. The New England journal of medicine 388 (3) (2023)
Lipika Goyal, Funda Meric-Bernstam, Antoine Hollebecque, Juan W Valle, Chigusa Morizane, Thomas B Karasic, Thomas A Abrams, Junji Furuse, Robin Kate Kelley, Philippe A Cassier, Heinz-Josef Klümpen, Heung-Moon Chang, Li-Tzong Chen, Josep Tabernero, Do-Youn Oh, Amit Mahipal, Markus Moehler, Edith P Mitchell, Yoshito Komatsu, Kunihiro Masuda, Daniel Ahn, Robert S Epstein, Abdel-Baset Halim, Yao Fu, Tehseen Salimi, Volker Wacheck, Yaohua He, Mei Liu, Karim A Benhadji, John A Bridgewater, null null
Futibatinib for FGFR2 -Rearranged Intrahepatic Cholangiocarcinoma. The New England journal of medicine 388 (3) (2023)
Xuyang Song, Robin Kate Kelley, Michelle L Green, Nathan Standifer, KyoungSoo Lim, Diansong Zhou, James Dunyak, Alejandra Negro, John F Kurland, Song Ren, Anis A Khan, Megan Gibbs, Ghassan K Abou-Alfa
Modeling of Proliferating CD4 and CD8 T-Cell Changes to Tremelimumab Exposure in Patients With Unresectable Hepatocellular Carcinoma. Clinical pharmacology and therapeutics (2023)
Paul V Munson, Juraj Adamik, Felix J Hartmann, Patricia M B Favaro, Daniel Ho, Sean C Bendall, Alexis J Combes, Matthew F Krummel, Karen Zhang, Robin Kate Kelley, Lisa H Butterfield
Polyunsaturated fatty acid-bound alpha-fetoprotein promotes immune suppression by altering human dendritic cell metabolism. Cancer research (2023)
Tim F Greten, Robert F Schwabe, Nabeel El-Bardeesy, Lichun Ma, Lipika Goyal, Robin Kate Kelley, Xin W Wang
Immunology and immunotherapy of cholangiocarcinoma. Nature reviews. Gastroenterology & hepatology (2023)
Kabir Mody, Prerna Jain, Sherif M El-Refai, Nilofer S Azad, Daniel J Zabransky, Nilofer S Azad, Rachna T Shroff, Robin Kate Kelley, Anthony B El-Khoueiry, Adam J Hockenberry, Denise Lau, Gregory B Lesinski, Mark Yarchoan
Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures. JCO precision oncology 6 (2022)
Andrew X Zhu, Farshid Dayyani, Chia-Jui Yen, Zhenggang Ren, Yuxian Bai, Zhiqiang Meng, Hongming Pan, Paul Dillon, Shivani K Mhatre, Vincent E Gaillard, Sairy Hernandez, Robin Kate Kelley, Bruno Sangro
Alpha-Fetoprotein as a Potential Surrogate Biomarker for Atezolizumab + Bevacizumab Treatment of Hepatocellular Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (16) (2022)
Xuyang Song, Robin Kate Kelley, Anis A Khan, Nathan Standifer, Diansong Zhou, KyoungSoo Lim, Rajesh Krishna, Lucy Liu, Kun Wang, Patricia McCoon, Alejandra Negro, Philip He, Megan Gibbs, John F Kurland, Ghassan K Abou-Alfa
Exposure-Response Analyses of Tremelimumab Monotherapy or in Combination with Durvalumab in Patients with Unresectable Hepatocellular Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Funda Meric-Bernstam, Rastislav Bahleda, Cinta Hierro, Marc Sanson, John A Bridgewater, Hendrik-Tobias Arkenau, Ben Tran, Robin Kate Kelley, Joon Oh Park, Milind Javle, Yaohua He, Karim A Benhadji, Lipika Goyal
Futibatinib, an irreversible FGFR1-4 inhibitor, in patients with advanced solid tumors harboring FGF/FGFR aberrations: a phase I dose-expansion study. Cancer discovery (2021)
Robin Kate Kelley, Bruno Sangro, William Harris, Masafumi Ikeda, Takuji Okusaka, Yoon-Koo Kang, Shu-Kui Qin, David Wai-Meng Tai, Ho Yeong Lim, Thomas Yau, Wei Peng Yong, Ann-Lii Cheng, Antonio Gasbarrini, Silvia Damian, Jordi Bruix, Mitesh J Borad, Johanna Bendell, Tae-You Kim, Nathan Standifer, Philip He, Mallory Makowsky, Alejandra Negro, Masatoshi Kudo, Ghassan K Abou-Alfa
Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (27) (2021)
Robin Kate Kelley, Rebecca Miksad, Irfan Cicin, YenHsun Chen, Heinz-Josef Klümpen, Stefano Kim, Zhong-Zhe Lin, Jillian Youkstetter, Saswati Hazra, Suvajit Sen, Ann-Lii Cheng, Anthony B El-Khoueiry, Tim Meyer, Ghassan K Abou-Alfa
Efficacy and safety of cabozantinib for patients with advanced hepatocellular carcinoma based on albumin-bilirubin grade. British journal of cancer (2021)
Robin Kate Kelley, Tim F Greten
Hepatocellular Carcinoma - Origins and Outcomes. The New England journal of medicine 385 (3) (2021)
Robin Kate Kelley, Patrick Mollon, Jean-Frédéric Blanc, Bruno Daniele, Thomas Yau, Ann-Lii Cheng, Velichka Valcheva, Florence Marteau, Ines Guerra, Ghassan K Abou-Alfa
Comparative Efficacy of Cabozantinib and Regorafenib for Advanced Hepatocellular Carcinoma. Advances in therapy 37 (6) (2020)
John D Gordan, Erin B Kennedy, Ghassan K Abou-Alfa, Muhammad Shaalan Beg, Steven T Brower, Terence P Gade, Laura Goff, Shilpi Gupta, Jennifer Guy, William P Harris, Renuka Iyer, Ishmael Jaiyesimi, Minaxi P Jhawer, Asha Karippot, Ahmed Omar Kaseb, Robin Kate Kelley, Jennifer J Knox, Jeremy Kortmansky, Andrea Leaf, William M Remak, Rachna T Shroff, Davendra P S Sohal, Tamar Hamosh Taddei, Neeta K Venepalli, Andrea Wilson, Andrew X Zhu, Michal G Rose
Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 38 (36) (2020)
Swetha Kambhampati, Kelly E Bauer, Paige M Bracci, Bridget P Keenan, Spencer C Behr, John D Gordan, Robin Kate Kelley
Nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh class B cirrhosis: Safety and clinical outcomes in a retrospective case series. Cancer 125 (18) (2019)
Maeve A Lowery, Laura W Goff, Bridget P Keenan, Emmet Jordan, Rui Wang, Andrea G Bocobo, Joanne F Chou, Eileen M O'Reilly, James J Harding, Nancy Kemeny, Marianela Capanu, Ann C Griffin, Joseph McGuire, Alan P Venook, Ghassan K Abou-Alfa, Robin Kate Kelley
Second-line chemotherapy in advanced biliary cancers: A retrospective, multicenter analysis of outcomes. Cancer 125 (24) (2019)
Huat C Lim, Meagan Montesion, Thomas Botton, Eric A Collisson, Sarah E Umetsu, Spencer C Behr, John D Gordan, Phil J Stephens, Robin Kate Kelley
Hybrid Capture-Based Tumor Sequencing and Copy Number Analysis to Confirm Origin of Metachronous Metastases in BRCA1-Mutant Cholangiocarcinoma Harboring a Novel YWHAZ-BRAF Fusion. The oncologist 23 (9) (2018)